https://scholars.lib.ntu.edu.tw/handle/123456789/113403
標題: | The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database | 作者: | Hsieh, Shu-Ching Lai, Jung-Nien Lee, Chuan-Fang Hu, Fu-Chang Tseng, Wei-Lum Wang, Jung-Der |
關鍵字: | prescription patterns;Chinese herbal products;cross- sectional data analysis;data mining | 公開日期: | 2008 | 起(迄)頁: | 609-619 | 來源出版物: | Pharmacoepidemiology and Drug Safety | 摘要: | Purpose The consumption of Chinese herbal products (CHPs) is increasing exponentially. However, the scientific evidence is lacking and there is an urgent requirement for detailed pharmacoepidemiological information on CHP usage. This study was to investigate CHP prescription patterns in Taiwan. Methods We carried out a cross-sectional analysis on a cohort of 200 000 patients based on 2004 data from the National Health Insurance ( NHI) reimbursement database. Data mining techniques were applied to explore CHP co- prescription patterns. Results A total of 46938 patients had been prescribed CHPs on at least one occasion in 2004. Patients using CHPs were generally female and middle-aged, made more outpatient visits, had fewer hospitalizations and consumed more medical resources than non- users of CHPs. A total of 1073 030 CHPs were contained within 220 123 prescriptions, for which acute nasopharyngitis was the most common indication. Yan hu suo and Jia Wei Xiao Yao San were the most frequently prescribed single herb (SH) and herbal formula (HF), respectively. The results of the data mining showed that the best predictions were provided by co- prescriptions of 'Mo yao and Ru xiang', 'Ye jiao teng and Suan Zao Ren Tan' and 'Dang Gui Nian Tong Tang and Shu Jing Huo Xue Tang' in the groups of SH-SH, SH-HF and HF-HF, respectively. Conclusions This study provides national-level CHP prescription profiles and utilization rates, and documents, for the first time, HF-HF prescription combinations in Chinese medicine (CM) practices in Taiwan. We conclude that more studies are needed to validate the safety and effectiveness of CHP prescriptions. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/161174 | DOI: | 10.1002/pds.1611 | SDG/關鍵字: | Angelica extract; ban xia xie xin tang; Carthamus extract; Chinese drug; chuan qiong cha diao san; Cyperi extract; dang gui nian tong tang; du huo ji shen tang; Fritillariae extract; Glycyrrhiza uralensis extract; herbaceous agent; Houttuynia cordata extract; isatis extract; jia wei xiao yao san; ma xing gan shi tang; Myrrha extract; ping wei san; plant medicinal product; Platycodon grandiflorum extract; premaelle; Pueraria extract; Salvia miltiorrhiza extract; Scutellariae radix; shao yao gan cao tang; shin yi ching fey tang; shu jing huo xue tang; suan zao ren tang; unindexed drug; yan hu suo; ye jiao teng; yin qiao san; adolescent; adult; aged; allergic rhinitis; article; backache; Chinese medicine; cohort analysis; controlled study; cross-sectional study; data base; drug efficacy; drug formulation; drug safety; drug utilization; female; hospitalization; human; major clinical study; male; menstruation disorder; national health insurance; outpatient; prescription; priority journal; reimbursement; respiratory tract disease; rhinopharyngitis; sleep disorder; Taiwan; age; child; clinical practice; drug combination; factual database; middle aged; pharmacoepidemiology; sex difference; statistics; Adolescent; Adult; Age Factors; Aged; Child; Cross-Sectional Studies; Databases, Factual; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Pharmacoepidemiology; Physician's Practice Patterns; Sex Factors; Taiwan |
顯示於: | 流行病學與預防醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。